BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3292)

  • 1. [Changes in transmitter release at frog neuromuscular junction induced by 4-aminopyridine].
    Molgo J; Lemeignan M; Lechat P
    C R Acad Hebd Seances Acad Sci D; 1975 Nov; 281(21):1637-9. PubMed ID: 3292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 4-aminopyridine at the frog neuromuscular junction.
    Molgo J; Lemeignan M; Lechat P
    J Pharmacol Exp Ther; 1977 Dec; 203(3):653-63. PubMed ID: 21957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of aldrin-transdiol on neuromuscular facilitation and depression.
    Akkermans LM; van den Bercken J; van der Zalm J
    Eur J Pharmacol; 1975 Apr; 31(2):166-75. PubMed ID: 238851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the action of 4-aminopyridine during repetitive stimulation at the neuromuscular junction.
    Molgó J; Lemeignan M; Lechat P
    Eur J Pharmacol; 1979 Jan; 53(3):307-11. PubMed ID: 32061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in spontaneous and evoked release of transmitter induced by the crotoxin complex and its component phospholipase A2 at the frog neuromuscular junction.
    Hawgood BJ; Santana de Sa S
    Neuroscience; 1979; 4(2):293-303. PubMed ID: 34124
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction.
    Molgó J; del Pozo E; Baños JE; Angaut-Petit D
    Br J Pharmacol; 1991 Sep; 104(1):133-8. PubMed ID: 1686201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 4-aminopyridine on neuromuscular transmission.
    Lundh H
    Brain Res; 1978 Sep; 153(2):307-18. PubMed ID: 210882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in transmitter release from motor nerve terminals induced by some pyridine derivatives.
    Montoya GA; Molgó J; Lemeignan M; Lechat P
    Acta Physiol Pharmacol Latinoam; 1984; 34(4):409-18. PubMed ID: 6242265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the facilitatory actions of 4-aminopyridine methiodide and 4-aminopyridine on neuromuscular transmission.
    Horn AS; Lambert JJ; Marshall IG
    Br J Pharmacol; 1979 Jan; 65(1):53-62. PubMed ID: 216450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification by lithium of transmitter release at the neuromuscular junction of the frog.
    Branisteanu DD; Volle RL
    J Pharmacol Exp Ther; 1975 Aug; 194(2):362-72. PubMed ID: 239225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The action of cobalt ions on neuromuscular transmission in the frog.
    Weakly JN
    J Physiol; 1973 Nov; 234(3):597-612. PubMed ID: 4357999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromuscular transmission in a mammalian preparation in the absence of blocking drugs and the effect of D-tubocurarine.
    Hubbard JI; Wilson DF
    J Physiol; 1973 Jan; 228(2):307-25. PubMed ID: 4346989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the time course of transmitter action produced by procaine.
    Hirst GD; Wood DR
    Br J Pharmacol; 1971 Jan; 41(1):105-12. PubMed ID: 4396126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 4-aminopyridine and 3,4-diaminopyridine on transmitter release at the neuromuscular junction.
    Thomsen RH; Wilson DF
    J Pharmacol Exp Ther; 1983 Oct; 227(1):260-5. PubMed ID: 6137556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged nerve stimulation causes changes in transmitter release at the frog neuromuscular junction.
    Hinz I; Wernig A
    J Physiol; 1988 Jul; 401():557-65. PubMed ID: 2902219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium dependence of evoked transmitter release at very low quantal contents at the frog neuromuscular junction.
    Andreu R; Barrett EF
    J Physiol; 1980 Nov; 308():79-97. PubMed ID: 6112267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in presynaptic action of 4-aminopyridine and tetraethylammonium at frog neuromuscular junction.
    Glavinović MI
    Can J Physiol Pharmacol; 1987 May; 65(5):747-52. PubMed ID: 2887267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relation between quantum content and facilitation at the neuromuscular junction of the frog.
    Mallart A; Martin AR
    J Physiol; 1968 Jun; 196(3):593-604. PubMed ID: 4298821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential sensitivity to Mg(2+)-and tubocurarine-block of frog neuromuscular junctions in summer and winter.
    Wernig A; Dorlöchter M; Palazis P
    Neurosci Lett; 1996 Mar; 207(1):41-4. PubMed ID: 8710205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of the dissociation constant of d-tubocurarine and the receptor for endogenous acetylcholine.
    Bowen JM
    J Pharmacol Exp Ther; 1972 Nov; 183(2):333-40. PubMed ID: 4343415
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.